Zofran Information
What's inside Zofran
Zofran Active Ingredients: ondansetron hydrochloride, details.| Zofran Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Zofran 8 mg | tablet | oral | 1.0 each | OTC |
| Zofran 4 mg | tablet | oral | 1.0 each | OTC |
| Zofran 24 mg | tablet | oral | 1.0 each | OTC |
| Zofran 32 mg/50 mL | solution | intravenous | 50.0 milliliter(s) | OTC |
| Zofran 2 mg/mL | solution | injectable | 1.0 milliliter(s) | OTC |
| Zofran 4 mg/5 mL | solution | oral | 5.0 milliliter(s) | OTC |
Recent Zofran Side Effects
Posted by yellowdaisy 10 months ago
This medication has been very effective for me, who suffers from nausea on a frequent basis and does not know yet for a 100% ...
Posted by alphaomega 10 months ago
Stop taking drugs while pregnant!! Here, in the US, they kill our babies by making then sick through these drugs. In old time...
Posted by daysgoby05 12 months ago
I took Zofran after a terrible Migraine with severe vomiting. I was given it in the hospital and then I was on it for about ...
Zofran in the News
EURX: Positive Pharmacokinetic Study re Ondansetron vs GSK's Zofran(R) - Trading Markets (press release)
Ondansetron hydrochloride is marketed under the brand name Zofran(R) by GlaxoSmithKline for the treatment and prevention of chemotherapy-induced nausea and ...
Tue Feb 26 10:34:10 -0500 2008
Eurand Announces Positive Pharmacokinetic Study Results of Once-a ... - Primenewswire (press release)
Ondansetron hydrochloride is marketed under the brand name Zofran(r) by GlaxoSmithKline for the treatment and prevention of chemotherapy-induced nausea and ...
Tue Feb 26 09:14:46 -0500 2008
EURX: Positive Pharmacokinetic Study re Ondansetron vs GSK's Zofran(R) - Trading Markets (press release)
Ondansetron hydrochloride is marketed under the brand name Zofran(R) by GlaxoSmithKline for the treatment and prevention of chemotherapy-induced nausea and ...
Tue Feb 26 10:34:10 -0500 2008
Zofran Chemical Information
ondansetron hydrochloride - The hydrochloride salt of the racemic form of ondansetron, a carbazole derivative and a selective, competitive serotonin 5-HT3 receptor antagonist with antiemetic properties. Although its mechanism of action has not been fully characterized, ondansetron appears to competitively block the action of serotonin at 5HT3 receptors peripherally in the gastrointestinal tract as well as centrally in the area postrema of the CNS (the chemoreceptor trigger zone for vomiting), resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.
Zofran RSS Feed
